December 2025 in “Aesthetic Cosmetology and Medicine” This study emphasizes the need for personalized hair care strategies based on in-depth diagnostics, taking into account scalp type, environmental factors, and the microbiome, suggesting that this holistic approach could improve hair condition.
November 2024 in “International Journal of Research and Review” This review explores the application of nanotechnology in cosmetics, highlighting its role in enhancing skin penetration, sustaining drug action, and protecting against UV radiation, while also addressing regulatory considerations and potential exposure routes.
January 2024 in “Pharmacophore” This source discusses the potential of integrating herbal extracts with nanotechnology in skincare products, highlighting improved effectiveness and targeted delivery of active ingredients to skin cells compared to traditional formulations.
December 2023 in “International Journal For Multidisciplinary Research” This source reviews the application of various natural substances, particularly plant extracts from the Ayurvedic system, in promoting hair growth, addressing common issues like pigmentation, dandruff, and hair loss.
December 2023 in “International Research Journal of Modernization in Engineering Technology and Science” This study reviews the use and benefits of herbal cosmetics in addressing common hair issues like baldness, hair fall, and dandruff, highlighting that herbal products may offer fewer side effects than conventional beauty products.
May 2004 in “International Journal of Cosmetic Science” This study suggests that selecting and controlling emollient systems can regulate the skin penetration of active ingredients in cosmetic formulations, impacting their efficacy.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This research suggests that antifungal hair serums, incorporating essential oils and herbal extracts, may offer a promising alternative for managing microbial scalp disorders by improving drug penetration and stability compared to conventional treatments.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The authors discuss that antifungal hair serums with essential oils and herbal extracts show promise for managing microbial scalp disorders, as they might enhance drug delivery and patient adherence compared to traditional treatments like Ketoconazole, which can have side effects and limited effectiveness.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This source outlines Roota Hair Growth Serum® as a premium product combining natural ingredients and scientific research to target hair thinning and promote scalp health, claiming a positive impact on hair regrowth when used consistently over time.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This source describes Roota Hair Growth Serum® as a product designed to promote natural hair regrowth by improving scalp health and strengthening hair strands through a blend of natural ingredients and advanced hair-growth technology, supported by clinical testing.
December 2025 in “Revista Científica Sinapsis” This study highlights the need for personalized hair care plans based on scalp type and environmental factors, underscoring the importance of targeted product selection and the involvement of professionals to create effective solutions for modern lifestyle issues.
October 2025 in “Revista Científica de Estética e Cosmetologia” This study highlights the importance of creating customized, evidence-based hair care solutions by considering scalp types and environmental factors, confirming the effectiveness of multidisciplinary approaches integrating dermatology, cosmetology, and trichology to develop safe and efficient products and treatments.
November 2022 in “Zenodo (CERN European Organization for Nuclear Research)” This review discusses the impact of COVID-19 on hair loss, particularly in women, and explores potential treatments, but reports no new clinical results.
January 2022 in “International Journal of Health Science” The authors of this study aim to evaluate the strategies for using topical products in treating androgenetic alopecia, highlighting topical applications as potentially more effective and convenient compared to oral medications, which often suffer from poor patient adherence.
March 2026 in “Pharmaceutics” This review discusses therapeutic deep eutectic solvents as promising "green" solutions for enhancing drug solubility and delivery through the skin, reporting no new clinical results and highlighting future research directions.
September 2020 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers identified indometacin as a suitable active ingredient for a combination gel aimed at treating mastopathy and preventing breast cancer, establishing its concentration using literary analysis, marketing research, and in vitro biopharmaceutical methods.
95 citations
,
July 2015 in “European journal of pharmaceutics and biopharmaceutics” This review discusses the application of lipid nanoparticles for enhancing drug delivery through hair follicles and reports no new clinical results, emphasizing the potential role of sebum-like lipids in this context.
6 citations
,
September 2024 in “Metabolism and Target Organ Damage” This review discusses the role of skin enzymes in drug metabolism and emphasizes the need for models assessing enzyme activity to evaluate the safety and bioequivalence of topical generic drugs, highlighting efforts to standardize testing protocols for transdermal products.
2 citations
,
December 2021 This study found that the observed isotropic ss-ECD spectrum of finasteride is influenced by the anisotropy of locally oriented crystals, offering new possibilities for analyzing solid-state chiral materials.
1 citations
,
October 2020 in “Annales pharmaceutiques françaises” In this study, researchers developed and validated a rapid and robust chromatographic method to assess the concentration of Minoxidil and Finasteride in a new topical formulation for alopecia, demonstrating its ability to distinguish between different types of formulations using in vitro diffusion data.
In this study, researchers reported that hardshell capsules using the DiluCap® line of excipients demonstrated varying dissolution profiles under gastrointestinal-simulating conditions, with minoxidil and finasteride showing rapid release and melatonin and naltrexone displaying controlled release, indicating their suitability for different applications in compounding pharmacies.
January 2025 in “Journal of Pharmaceutical Research Science & Technology” This review explores the potential, challenges, and recent advancements of dissolving microneedles in drug delivery, summarizing their varied applications and current limitations without providing new clinical results.
August 2023 in “Scientia Pharmaceutica” In this study, researchers evaluated the stability and color changes of compounded minoxidil formulations used for alopecia, finding that while the formulations remained chemically and microbiologically stable for up to 380 days, significant color changes were observed, which likely do not affect the product's effectiveness.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This comprehensive guide from nanotechsci.com explores how nanocrystal technology enhances the bioavailability of poorly water-soluble pharmaceuticals, detailing the science behind crystallization and practical synthesis techniques, and discussing their advanced drug delivery applications across various routes.
January 2023 in “Anais do Congresso Brasileiro Interdisciplinar em Ciência e Tecnologia.” This study optimized conditions for quantifying minoxidil using high-performance liquid chromatography, establishing specific parameters for mobile phase, flow rate, column temperature, and retention time.
September 2020 in “Eureka: Health Sciences” In this study, the researchers developed an optimal emulgel formulation for treating androgenic alopecia, determining that a base with 0.3% Carbomer Ultraz 10, 0.1% potassium sorbate, and 0.2% triethanolamine offered the best properties for drug release, application compliance, safety, and stability.
1 citations
,
August 2024 in “Expert Opinion on Drug Safety” This study analyzed data from the FDA Adverse Event Reporting System and found that finasteride had the highest reporting frequency and signal strength for drug-induced erectile dysfunction among 734 drugs, with compound preparations posing higher risks than single ingredients.
June 2026 in “HAL (Le Centre pour la Communication Scientifique Directe)” This infographic compares the safety profiles of SH‑1, a cosmetic ingredient, which showed no systemic absorption, and PP405, an investigational drug with dose-dependent systemic uptake and potential threshold breaches, highlighting differences in safety between cosmetic and investigational substances according to this report.
March 2005 in “Journal of The American Academy of Dermatology” Two lotions used day and night may be a good alternative to minoxidil for hair loss, with better cosmetic effects and tolerance.
March 2005 in “Journal of The American Academy of Dermatology” The two lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.